Your browser doesn't support javascript.
loading
A CRISPR/Cas9 engineered MplS504N mouse model recapitulates human myelofibrosis.
Adriaanse, Fabienne R S; Kamens, Jennifer L; Vogel, Peter; Sakurada, Sadie M; Pruett-Miller, Shondra M; Stam, Ronald W; Michel Zwaan, C; Gruber, Tanja A.
Afiliação
  • Adriaanse FRS; Department of Pediatric Oncology, Erasmus MC-Sophia's Children's Hospital, Rotterdam, The Netherlands.
  • Kamens JL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Vogel P; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
  • Sakurada SM; Department of Pathology, St Jude Children's Research Hospital, Memphis, TN, USA.
  • Pruett-Miller SM; Center for Advanced Genome Engineering (CAGE), St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Stam RW; Center for Advanced Genome Engineering (CAGE), St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Michel Zwaan C; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Gruber TA; Department of Pediatric Oncology, Erasmus MC-Sophia's Children's Hospital, Rotterdam, The Netherlands.
Leukemia ; 36(10): 2535-2538, 2022 10.
Article em En | MEDLINE | ID: mdl-35999261

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mielofibrose Primária Limite: Animals / Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mielofibrose Primária Limite: Animals / Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda